IBEX vs NNDM

IBEX exhibits exceptional fundamental health with a Piotroski F-Score of 8/9, indicating strong financial stability and operational efficiency. The stock is currently trading at $27.49, which is essentially at its Graham Number ($27.9) and significantly below its growth-based intrinsic value of $88.79. Despite a bearish technical trend and recent insider selling by the CEO, the combination of a low P/E (9.13), high ROE (33.65%), and robust earnings growth (45.6% YoY) presents a compelling value opportunity.

NNDM exhibits critical financial weakness, highlighted by a Piotroski F-Score of 0/9, indicating a complete lack of fundamental improvement across all health metrics. While the company maintains an exceptionally strong liquidity position (Current Ratio 10.02) and low debt, these are overshadowed by severe profitability issues, including a profit margin of -286.32%. Despite impressive triple-digit revenue growth, the company continues to destroy shareholder value, as evidenced by a 75.6% decline over five years. The stock is currently a speculative play on revenue growth rather than a viable value investment.